REFERENCES
1. Bogani G, Murgia F, Ditto A, Raspagliesi F. Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol. 2019;153(3):676–83.
2. Pölcher M, Rottmann M, Brugger S, Mahner S, Dannecker C, Kiechle M, et al. Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients. Gynecol Oncol. 2019;154(1):65–71.
3. Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer. 2016;26(1):2–30.
4. Prodromidou A, Machairas N, Spartalis E, Kostakis ID, Iavazzo C, Moris D, et al. Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis. Anticancer Res. 2018;38(8):4677–81.
5. Ind T, Laios A, Hacking M, Nobbenhuis M. A comparison of operative outcomes between standard and robotic laparoscopic surgery for endometrial cancer: A systematic review and meta-analysis. Int J Med Robot. 2017;13(4):e1851.
6. Kuroda K, Yamamoto Y, Yanagisawa M, Kawata A, Akiba N, Suzuki K, et al. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: A hospital-based retrospective cohort study. BMC Womens Health. 2017;17(1):50.
7. Kondalsamy-Chennakesavan S, Janda M, Gebski V, Baker J, Brand A, Hogg R, et al. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial. Eur J Cancer. 2012;48(14):2155–62.
8. Shim SH, Lee SJ, Dong M, Suh JH, Kim SY, Lee JH, et al. Prediction model for 30-day morbidity after gynecological malignancy surgery. PLoS One. 2017;12(6):e0178610.
9. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, et al. Predictors and costs of surgical site infections in patients with endometrial cancer. Gynecol Oncol. 2013;130(1):100–6.
10. Gerestein CG, Nieuwenhuyzen-de Boer GM, Eijkemans MJ, Kooi GS, Burger CW. Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer. Eur J Cancer. 2010;46(1):102–9.
11. Giugale LE, Di Santo N, Smolkin ME, Havrilesky LJ, Modesitt SC. Beyond mere obesity: Effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012;127(2):326–31.
12. Orekoya O, Samson ME, Trivedi T, Vyas S, Steck SE. The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review. J Gynecol Surg. 2016;32(3):149–57.
13. Uccella S, Bonzini M, Palomba S, Fanfani F, Ceccaroni M, Seracchioli R, et al. Impact of Obesity on Surgical Treatment for Endometrial Cancer: A Multicenter Study Comparing Laparoscopy vs Open Surgery, with Propensity-Matched Analysis. J Minim Invasive Gynecol. 2016;23(1):53–61.
14. Aune D, Navarro Rosenblatt DA, Chan DSM, Vingeliene S, Abar L, Vieira AR, et al. Anthropometric factors and endometrial cancer risk: A systematic review and dose-response meta-analysis of prospective studies. Ann Oncol. 2015;26(8):1635–48.
15. Seki Y, Ohue M, Sekimoto M, Takiguchi S, Takemasa I, Ikeda M, et al. Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index. Surg Endosc. 2007;21(6):929–34.
16. Kang J, Baek S-E, Kim T, Hur H, Min BS, Lim JS, et al. Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index. Int J Colorectal Dis. 2012;27(4):497–505.
17. Watanabe J, Tatsumi K, Ota M, Suwa Y, Suzuki S, Watanabe A, et al. The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer. Int J Colorectal Dis. 2014;29(3):343–51.
18. Ballian N, Lubner MG, Munoz A, Harms BA, Heise CP, Foley EF, et al. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma. J Surg Oncol. 2012;105(4):365–70.
19. Palomba S, Zupi E, Russo T, Oppedisano R, Manguso F, Falbo A, et al. Presurgical assessment of intraabdominal visceral fat in obese patients with early-stage endometrial cancer treated with laparoscopic approach: Relationships with early laparotomic conversions. J Minim Invasive Gynecol. 2007;14(2):195–201.
20. Zamboni M, Turcato E, Armellini F, Kahn H, Zivelonghi A, Santana H, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes. 1998;22(7):655–60.
21. Molokhia AA. Waist circumference is better than body mass index, but sagittal anterior diameter may be even better. Br J Anaesth. 2017;118(2):274.
22. Biswas N, Hogston P. Surgical risk from obesity in gynaecology. Obstet Gynaecol. 2011;13(2):87–91.
23. Díaz-Feijoo B, Bebia V, Hernández A, Gilabert-Estalles J, Franco-Camps S, de la Torre J, et al. Surgical complications comparing extraperitoneal vs transperitoneal laparoscopic aortic staging in early stage ovarian and endometrial cancer. Gynecol Oncol. 2021;160(1):83-90.
24. Díaz-Feijoo B, Correa-Paris A, Pérez-Benavente A, Franco-Camps S, Sánchez-Iglesias JL, Cabrera S, et al. Prospective Randomized Trial Comparing Transperitoneal Versus Extraperitoneal Laparoscopic Aortic Lymphadenectomy for Surgical Staging of Endometrial and Ovarian Cancer: The STELLA Trial. Ann Surg Oncol. 2016;23(9):2966–74.
25. Yim JY, Kim D, Lim SH, Park MJ, Choi SH, Lee CH, et al. Sagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General Population. Diabetes Care. 2010;33(12):2665–70.
26. Dell-Kuster S, Gomes N V., Gawria L, Aghlmandi S, Aduse-Poku M, Bissett I, et al. Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study. BMJ. 2020;370:1–11.
27. Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications. Ann Surg. 2004;240(2):205–13.
28. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.
29. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60.
30. Chinchilli VM, Martel JK, Kumanyika S, Lloyd T. A Weighted Concordance Correlation Coefficient for Repeated Measurement Designs. Biometrics. 1996;52(1):341.
31. Salman MC, Usubutun A, Ozlu T, Boynukalin K, Yuce K. Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers. J Gynecol Oncol. 2010;21(1):24.
32. Helm CW, Arumugam C, Gordinier ME, Metzinger DS, Pan J, Rai SN. Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications. J Gynecol Oncol. 2011;22(3):168.
33. Harrison RF, Mcnamara JE, Beaumont CB, Sadowski EA, Chappell RJ, Shahzad MM, et al. Using simple radiologic measurements to anticipate surgical challenge in endometrial cancer: a prospective study. Int J Gynecol Cancer. 2019;29(1):102–7.
34. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012;127(1):5–10.
35. Doll KM, Barber EL, Bensen JT, Revilla MC, Snavely AC, Bennett A V., et al. The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study. Am J Obstet Gynecol. 2016;215(4):457.e1-457.e13.
36. Clark RM, Lee MS, Alejandro Rauh‐Hain J, Hall T, Boruta DM, del Carmen MG, et al. Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy. Gynecol Oncol. 2015;136(3):516–20.
37. Bhandoria G, Mane JD. Can Surgical Apgar Score (SAS) Predict Postoperative Complications in Patients Undergoing Gynecologic Oncological Surgery? Indian J Surg Oncol. 2020;11(1):60–5.
38. Teoh D, Halloway RN, Heim J, Vogel RI, Rivard C. Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery. J Minim Invasive Gynecol. 2017;24(1):48–54.
39. Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, et al. Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications). Br J Cancer. 2015;112(3):475–84.
40. Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2012;207(2):94–100.
41. Barrie A, Freeman AH, Lyon L, Garcia C, Conell C, Abbott LH, et al. Classification of Postoperative Complications in Robotic-assisted Compared With Laparoscopic Hysterectomy for Endometrial Cancer. J Minim Invasive Gynecol. 2016;23(7):1181–8.
42. Jørgensen SL, Mogensen O, Wu C, Lund K, Iachina M, Korsholm M, et al. Nationwide Introduction of Minimally Invasive Robotic Surgery for Early-Stage Endometrial Cancer and Its Association With Severe Complications. JAMA Surg. 2019;154(6):530.
43. The COMET Initiative. COMET database [Internet]. [cited 2020 Nov 20]. Available from: https://www.comet-initiative.org/studies/